The rat left lung orthotopic transplantation model is an essential tool in lung transplant research. Although lung transplantation is a complex procedure, its complexity is significantly reduced with the introduction of the cuff technique. Most surgeons can master this technique after training, but its application has been limited due to the long learning curve and low model survival rate. To address these issues, we propose an improved technique with high repeatability, which includes donor lung harvest, modification, and implantation. Compared to previous methods, our improvements primarily focus on the dissection of the donor lung harvest, donor lung modification, and donor lung implantation. This modification simplifies the procedure, reduces operational difficulty, and increases repeatability. Additionally, the cold ischemia and warm ischemia times during the procedure have been shortened, further improving the success rate of transplantation. Our research provides a more efficient and reproducible technical foundation for the rat lung transplantation model, supporting future research in lung transplantation.
27 November 2023 in Open Forum Infectious Diseases
Nocardia commonly infects lung transplant recipients (LTR). Current oral options for long-term therapy may result in intolerance or adverse events. Contezolid is a new oxazolidinone antibiotic with potential less toxicity than linezolid that was approved in China. This study describes the use of contezolid in the treatment of nocardiosis among LTR. This retrospective study reviewed clinical data of adult LTR who were complicated with nocardiosis between January-2018 and December-2022 at the large transplant center China. Diagnosis of nocardiosis was confirmed by high resolution CT and cultures from representative samples. Nocardia spp. were identified by metagenomic next generation sequencing (mNGS). Drug susceptibility was determined by E-Test for TMP-SMX, Imipenem and Linezolid, and Kirby-Bauer for the others. Patients were followed in hospital and during home therapy for the whole duration of the treatment. Cure was defined by resolution of clinical symptoms, CT scan and culture negative BAL. Our study suggests that contezolid can be used in the long-term treatment of nocardiosis among lung transplant recipients. All Authors: No reported disclosures
Purpose: Nocardiosis is an opportunistic infection in lung transplant recipients but is often misdiagnosed or overlooked. This study aimed to identify risk factors and develop an effective predictive model for nocardiosis in this population. Patients and Methods: This single-center retrospective study analyzed 679 lung transplant recipients from January 1, 2015, to July 9, 2024. Twenty patients with nocardiosis were compared with 40 matched controls. Feature selection was performed using LASSO regression, and logistic regression identified risk factors. Model performance was assessed via ROC curves, calibration curves, and decision curve analysis. Results: Decreased CD4+ T cells, elevated CD8+ T cells, and reduced IgA levels were significantly associated with nocardiosis (P < 0.05). The model incorporating these factors demonstrated strong predictive ability with an area under the ROC curve of 0.955. Conclusion: CD4+ T cells, CD8+ T cells, and IgA are independent risk factors for nocardiosis post-lung transplantation. The developed model effectively distinguishes nocardiosis cases, aiding early clinical identification.